Nomura Holdings Inc. Makes New Investment in Semler Scientific Inc. $SMLR

Key Points

• Nomura Holdings Inc. has acquired a new stake in Semler Scientific Inc., purchasing 35,762 shares valued at approximately $1.295 million, representing about 0.37% ownership.
• Semler Scientific reported a strong earnings performance with $5.04 earnings per share for the quarter, significantly beating analysts' expectations of ($0.27).
• Several hedge funds have increased their positions in Semler Scientific, highlighting a strong interest in the company, with institutional investors owning 49.37% of its stock.

Nomura Holdings Inc. purchased a new stake in shares of Semler Scientific Inc. (NASDAQ:SMLR - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 35,762 shares of the company's stock, valued at approximately $1,295,000. Nomura Holdings Inc. owned about 0.37% of Semler Scientific at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Cambridge Investment Research Advisors Inc. grew its holdings in Semler Scientific by 10.2% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 6,226 shares of the company's stock worth $225,000 after purchasing an additional 576 shares during the period. GAMMA Investing LLC boosted its position in shares of Semler Scientific by 49,133.3% during the 1st quarter. GAMMA Investing LLC now owns 7,385 shares of the company's stock worth $267,000 after purchasing an additional 7,370 shares in the last quarter. Nuveen Asset Management LLC grew its stake in shares of Semler Scientific by 396.9% in the 4th quarter. Nuveen Asset Management LLC now owns 124,548 shares of the company's stock valued at $6,726,000 after buying an additional 99,482 shares during the period. MetLife Investment Management LLC bought a new stake in Semler Scientific in the 4th quarter valued at about $163,000. Finally, Nuveen LLC acquired a new position in Semler Scientific during the 1st quarter worth approximately $990,000. 49.37% of the stock is owned by institutional investors.

Semler Scientific Stock Up 0.1%

NASDAQ:SMLR traded up $0.03 on Friday, hitting $28.12. The stock had a trading volume of 415,040 shares, compared to its average volume of 525,773. Semler Scientific Inc. has a 1 year low of $21.77 and a 1 year high of $81.56. The firm's fifty day simple moving average is $36.18 and its two-hundred day simple moving average is $36.45. The company has a debt-to-equity ratio of 0.25, a quick ratio of 0.58 and a current ratio of 0.60. The stock has a market cap of $416.46 million, a P/E ratio of 3.34 and a beta of 1.39.

Semler Scientific (NASDAQ:SMLR - Get Free Report) last released its earnings results on Monday, August 4th. The company reported $5.04 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.27) by $5.31. Semler Scientific had a return on equity of 43.84% and a net margin of 86.20%.The company had revenue of $8.22 million during the quarter, compared to analyst estimates of $8.10 million.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on SMLR shares. Benchmark initiated coverage on Semler Scientific in a research note on Tuesday, July 8th. They issued a "buy" rating and a $101.00 price objective for the company. Cantor Fitzgerald reduced their price target on shares of Semler Scientific from $61.00 to $60.00 and set an "overweight" rating for the company in a research report on Wednesday, August 6th. Maxim Group upgraded shares of Semler Scientific to a "strong-buy" rating and set a $95.00 price target for the company in a research note on Wednesday, July 9th. Finally, Wall Street Zen lowered shares of Semler Scientific from a "buy" rating to a "sell" rating in a research note on Thursday, May 22nd. One research analyst has rated the stock with a Strong Buy rating and three have assigned a Buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Buy" and an average target price of $81.75.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.